diagnost
system
lassa
fever
lf
viral
hemorrhag
fever
caus
lassa
viru
lasv
enzym
immunoassay
detect
lasv
antibodi
lasv
antigen
develop
use
recombin
nucleoprotein
rnp
lasv
lasvrnp
lasvrnp
express
recombin
baculoviru
system
lasvrnp
use
antigen
detect
lasvantibodi
immunogen
product
monoclon
antibodi
lasvrnp
also
express
hela
cell
transfect
express
vector
encod
cdna
lasvnp
gene
immunoglobulin
g
enzymelink
immunosorb
assay
elisa
use
lasvrnp
indirect
immunofluoresc
assay
use
lasvrnpexpress
hela
cell
confirm
high
sensit
specif
detect
lasvantibodi
novel
monoclon
antibodi
lasvrnp
monoclon
antibodi
establish
sandwich
antigen
captur
agcaptur
elisa
use
monoclon
antibodi
antilasvrnp
rabbit
serum
captur
detect
antibodi
respect
develop
authent
lasv
nucleoprotein
serum
sampl
collect
hamster
experiment
infect
lasv
detect
agcaptur
elisa
agcaptur
elisa
specif
detect
lasvrnp
rnp
lymphocyt
choriomening
viru
junin
viru
sensit
agcaptur
elisa
detect
lasv
antigen
compar
revers
transcriptionpcr
detect
lasv
rna
lasv
rnpbase
diagnost
confirm
use
diagnosi
lf
even
institut
without
high
contain
laboratori
sinc
antigen
prepar
without
manipul
infecti
virus
materi
method
hela
cell
line
cultur
eagl
minimum
essenti
medium
supplement
fetal
bovin
serum
antibiot
penicillin
g
streptomycin
insect
cell
use
express
rnp
arenavirus
lasv
lymphocyt
choriomening
viru
lcmv
junin
viru
junv
baculoviru
system
insect
cell
cultur
report
previous
lassa
fever
lf
viral
hemorrhag
fever
caus
lassa
viru
lasv
old
world
arenaviru
mani
case
lf
occur
western
africa
countri
guinea
sierra
leon
nigeria
thought
lasv
infect
ten
thousand
human
annual
caus
hundr
thousand
death
human
becom
infect
contact
infect
excreta
tissu
blood
peridomest
rodent
mastomi
natalensi
reservoir
host
lasv
lasv
transmit
human
via
mucos
cutan
contact
nosocomi
contamin
import
case
lf
report
outsid
endem
region
area
unit
state
canada
europ
japan
recent
potenti
use
hemorrhag
fever
virus
includ
lasv
biolog
weapon
emphas
therefor
develop
diagnost
system
lf
import
even
countri
free
lf
outbreak
date
manipul
infecti
lasv
necessari
detect
specif
antibodi
howev
highcontain
laboratori
biosafeti
level
requir
handl
infecti
lasv
therefor
prepar
lasv
antigen
implement
institut
without
facil
within
framework
import
develop
sensit
specif
diagnost
system
lf
elimin
need
manipul
infecti
lasv
present
studi
recombin
nucleoprotein
rnp
lasv
lasvrnp
express
evalu
abil
detect
lasv
antibodi
lasvrnpbas
enzymelink
immunosorb
indirect
immunofluoresc
assay
elisa
iifa
develop
furthermor
novel
monoclon
antibodi
lasvrnp
gener
use
combin
recombin
antigen
develop
lasv
antigen
nucleoprotein
captur
elisa
present
studi
present
altern
strategi
develop
diagnost
system
without
handl
infecti
lasv
clone
contain
insert
correct
orient
select
plasmid
dna
use
cotransfect
cell
polyhedrinposit
acmnpv
dna
supernat
cultur
screen
polyhedrinneg
phenotyp
plaqu
assay
final
recombin
baculoviru
clone
overexpress
junvrnp
obtain
three
success
plaqu
purif
one
design
use
present
studi
refer
hereaft
acjunvnp
express
purif
hislasvrnp
lcmvrnp
junvrnp
cell
infect
achislasvnp
incub
h
cell
wash
twice
cold
phosphatebuff
salin
pb
solut
preliminari
studi
demonstr
cellular
protein
solubil
pb
contain
urea
urea
hislasvrnp
insolubl
lasvrnp
could
solubil
pb
contain
urea
urea
therefor
cell
infect
achislasvnp
first
suspend
urea
centrifug
cell
suspens
g
min
pellet
fraction
collect
solubil
urea
centrifug
sampl
supernat
fraction
use
purifi
antigen
lcmvrnp
junvrnp
show
dissolut
characterist
urea
similar
hislasvrnp
therefor
lcmvrnp
junvrnp
also
fraction
way
hislasvrnp
control
antigen
produc
cell
infect
manner
posit
antigen
hislasvrnp
also
purifi
use
ni
column
purif
method
report
previous
sourc
hislasvrnppurif
supernat
fraction
ureatr
cell
infect
achislasvnp
suffici
dilut
pb
order
reduc
urea
concentr
sdspage
express
purif
effici
hislasvrnp
lcmvrnp
junvrnp
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
gel
polyacrylamid
stain
coomassi
blue
establish
mab
monoclon
antibodi
mab
gener
previous
describ
balbc
mice
immun
purifi
hislasvrnp
present
studi
isotyp
mab
determin
use
mous
mab
isotyp
kit
life
technolog
express
truncat
np
lasv
order
determin
epitop
mab
hislasvrnp
truncat
lasvrnp
express
form
fusion
protein
glutathion
stransferas
gst
shown
fig
dna
correspond
truncat
np
fragment
amplifi
design
primer
amplifi
dna
subclon
bamhi
ecori
clone
site
plasmid
amersham
pharmacia
biotech
buckinghamshir
england
insert
sequenc
confirm
correct
frame
ident
origin
sequenc
gsttag
nucleoprotein
fragment
express
escherichia
coli
system
western
blot
mab
test
reactiv
hislasvrnp
fragment
western
blot
report
previous
pepscan
analys
elisa
perform
report
previous
purifi
rnp
partial
nucleoprotein
peptid
antigen
peptid
shift
amino
acid
aa
consecut
overlap
aa
cover
entir
aa
aa
fragment
linear
epitop
np
determin
use
pepscan
chiron
technolog
clayton
australia
accord
manufactur
instruct
ninetysix
peptid
prepar
biotinyl
peptid
includ
spacer
sequenc
sgsg
aminotermin
end
accord
amino
acid
sequenc
lasv
josiah
strain
method
previous
describ
detail
iggelisa
immunoglobulin
g
igg
elisa
perform
previous
describ
except
antigen
prepar
briefli
elisa
plate
type
plate
probind
falcon
becton
dickinson
labwar
franklin
lake
nj
coat
predetermin
optim
quantiti
purifi
hislasvrnp
lcmvrnp
junvrnp
approxim
ngwell
overnight
well
plate
inocul
l
pb
contain
skim
milk
tween
mtpb
follow
incub
h
block
plate
wash
three
time
tpb
inocul
test
sampl
lwell
dilut
fourfold
mtpb
incub
period
plate
wash
three
time
tpb
plate
inocul
goat
antihuman
igg
antibodi
label
hrpo
dilut
zyme
laboratori
incub
period
plate
wash
l
abt
acid
solut
roch
diagnost
mannheim
germani
ad
well
plate
incub
min
room
temperatur
optic
densiti
nm
od
measur
refer
nm
adjust
od
calcul
subtract
od
neg
antigenco
well
correspond
well
mean
standard
deviat
calcul
control
sera
cutoff
valu
assay
defin
mean
plu
standard
deviat
immunofluoresc
digest
bamhi
insert
subclon
bamhi
site
vector
lasvnp
gene
insert
vector
confirm
correct
orient
promot
test
nucleotid
sequenc
describ
nucleotid
sequenc
gene
confirm
ident
origin
sequenc
hela
cell
transfect
use
transfect
reagent
roch
diagnost
accord
manufactur
instruct
cell
transfect
plasmid
select
g
blasticidin
shydrochlorideml
hela
cell
clone
analyz
express
lasvrnp
iifa
use
rabbit
serum
rais
hislasvrnp
cell
express
lasvrnp
subclon
use
iifa
antigen
agcaptur
elisa
agcaptur
elisa
perform
previous
describ
purifi
mab
hislasvrnp
mab
produc
present
studi
dilut
pb
solut
l
adsorb
overnight
onto
immunopl
type
plate
probind
falcon
becton
dickinson
labwar
purifi
mab
coat
onto
immunopl
concentr
approxim
ngwell
l
pb
differ
procedur
agcaptur
elisa
present
studi
previou
studi
mab
mab
rabbit
serum
rais
hislasvrnp
use
captur
detector
antibodi
respect
procedur
agcaptur
elisa
perform
follow
elisa
plate
coat
captur
mab
follow
block
plate
mtpb
addit
sampl
elisa
plate
detect
captur
lasvnp
rabbit
serum
rais
hislasvrnp
detect
rabbit
igg
antibodi
react
captur
antigen
goat
antirabbit
igg
antibodi
conjug
hrpo
zyme
laboratori
substrat
reaction
run
agcaptur
elisa
neg
control
antigen
mtpb
also
test
serial
dilut
sampl
ad
mabcoat
well
od
valu
well
adjust
subtract
od
valu
neg
control
antigen
correspond
well
adjust
od
taken
measur
amount
antigen
specif
bound
sampl
treat
pb
destroy
lasv
virion
expos
nucleoprotein
lasv
virion
rtpcr
rtpcr
perform
previous
describ
primer
use
rtpcr
rtpcr
carri
readytogo
rtpcr
tube
pharmacia
amplifi
pcr
product
visual
ethidium
bromid
agaros
gel
electrophoresi
march
guest
http
cviasmorg
treatment
wherea
rnp
virus
remain
insolubl
centrifug
g
min
pellet
fraction
collect
rnp
still
present
pellet
fraction
complet
solubil
urea
sampl
centrifug
g
min
supernat
fraction
urea
confirm
contain
highli
purifi
recombin
rnp
arenavirus
fig
develop
indirect
immunofluoresc
lasvrnp
express
hela
cell
transfect
express
vector
transfect
cell
stain
antihislasvrnp
rabbit
serum
human
serum
sampl
lf
patient
fig
serum
sampl
collect
two
lf
patient
show
posit
stain
control
serum
sampl
lasvrnpbas
iifa
also
evalu
use
serum
sampl
collect
monkey
experiment
infect
lasv
sera
collect
five
lasvinfect
monkey
show
posit
stain
four
mockinfect
monkey
develop
hislasvrnpbas
iggelisa
four
serum
sampl
collect
lf
patient
determin
posit
hislasvrnpbas
iggelisa
wherea
control
serum
sampl
determin
neg
thu
sensit
specif
elisa
respect
serum
sampl
collect
five
lasvinfect
monkey
determin
posit
wherea
four
mockinfect
monkey
neg
order
examin
crossreact
among
arenavirus
lasvrnpbas
iggelisa
antisera
lasvrnp
lcmvrnp
junvrnp
examin
fig
antilasvrnp
serum
show
strongli
posit
reaction
antilcmv
rnp
antijunvrnp
sera
show
strongli
posit
reaction
igg
elisa
use
respect
antigen
fig
b
c
antilcmvrnp
antijunvrnp
sera
show
less
strongli
posit
reaction
hislasvrnpbas
iggelisa
antilasvrnp
serum
fig
antilasvrnp
antijunvrnp
also
show
less
strongli
posit
reaction
hislcmvrnpbas
iggelisa
antilcmvrnp
serum
fig
howev
antilasvrnp
antilcmvrnp
sera
show
neg
reaction
junvrnpbas
iggelisa
fig
human
sera
lf
patient
show
highli
posit
reaction
lasvrnpbas
iggelisa
sera
patient
argentin
hemorrhag
fever
ahf
caus
junv
fig
serum
ahf
patient
show
highli
posit
reaction
junvrnpbas
iggelisa
fig
result
suggest
crossreact
antibodi
among
arenavirus
may
detect
newli
develop
lasvrnpbas
iggelisa
develop
lasv
agcaptur
elisa
three
clone
hybridoma
excret
mab
hislasvrnp
es
tablish
isotyp
three
mab
identifi
mab
design
mab
mab
mab
mab
mab
effici
captur
hislasvrnp
agcaptur
elisa
format
agcaptur
elisa
mab
detect
hislasvrnp
concentr
low
pgml
data
shown
furthermor
agcaptur
elisa
detect
mopvnp
rnp
lcmv
junv
data
shown
sera
collect
five
lasvinfect
hamster
day
postinfect
antigen
posit
agcaptur
elisa
use
mab
captur
antibodi
wherea
sera
collect
day
antigen
neg
od
valu
elisa
highest
day
reactiv
pattern
hamster
elisa
similar
viremia
level
fig
sera
collect
day
found
lasv
genom
posit
rtpcr
thu
sensit
agcaptur
elisa
similar
rtpcr
determin
epitop
recogn
monoclon
antibodi
epitop
recogn
mab
determin
react
western
blot
fulllength
lasvrnp
truncat
lasvrnp
shown
tabl
suggest
mab
react
conform
epitop
locat
aminotermin
portion
lasvrnp
epitop
maintain
extrem
aminotermin
portion
present
lost
remov
result
suggest
extrem
aminotermin
portion
essenti
mainten
conform
epitop
mab
react
western
blot
respect
tabl
pepscan
analys
indic
mab
nd
nd
nd
nd
indic
posit
neg
reaction
respect
nd
determin
b
indic
lasvrnp
fig
reactiv
pattern
mab
np
lasv
mopv
lcmv
junv
summar
tabl
report
develop
diagnost
system
antibodi
antigen
detect
system
lf
use
lasvrnp
lasvrnpbas
iggelisa
sensit
specif
detect
antilasvigg
although
data
shown
igmcaptur
elisa
use
purifi
lasvrnp
antigen
develop
way
shown
previou
report
detect
lasvigm
antibodi
sera
collect
lf
patient
monkey
infect
lasv
show
posit
reaction
lasvrnpbas
iifa
stain
pattern
rnp
sera
granular
iifa
fig
make
easi
distinguish
posit
neg
iifa
use
lasvrnpexpress
hela
cell
also
highli
sensit
specif
detect
lasvigg
preliminari
studi
ca
sera
collect
ghanaian
less
zambian
show
posit
reaction
lasvrnpbas
igg
elisa
data
result
consid
compat
fact
lf
endem
western
african
region
includ
ghana
eastern
african
region
lasvrnpbas
antibodi
detect
system
elisa
iifa
suggest
use
diagnosi
also
seroepidemiolog
studi
lf
lasvrnp
express
transform
system
e
coli
recombin
baculoviru
system
alreadi
appli
antigen
elisa
western
blot
iifa
detect
antibodi
lasv
present
studi
agcaptur
elisa
use
nd
indic
posit
neg
reaction
respect
nd
determin
reactiv
mab
mab
evalu
mopvnp
howev
theoret
mab
reactiv
mopvnp
due
presenc
amino
acid
residu
react
mab
mab
react
mopvnp
due
absenc
amino
acid
residu
react
mab
mab
lasvrnp
also
develop
furthermor
detect
crossreact
antibodi
lasvrnpbas
iggelisa
examin
result
crossreact
indic
lasvrnpbas
iggelisa
detect
antibodi
lasv
also
lcmv
agcaptur
elisa
use
mab
confirm
use
detect
authent
lasv
antigen
sera
serial
collect
hamster
infect
lasv
sensit
mab
agelisa
similar
convent
rtpcr
effici
diagnosi
lf
previous
report
therefor
mab
agcaptur
elisa
regard
use
diagnosi
lf
unfortun
efficaci
mab
agcaptur
elisa
diagnosi
lf
evalu
use
serum
sampl
patient
thu
studi
still
requir
three
mab
includ
mab
character
correspond
amino
acid
residu
within
nucleoprotein
lasv
mopv
lcmv
junv
epitop
mab
mab
summar
fig
interest
lasv
mopv
lcmv
junv
might
identifi
analys
reactiv
pattern
mab
nucleoprotein
viru
nucleoprotein
lasv
strain
circul
western
central
part
africa
would
detect
mab
agcaptur
elisa
sinc
elisa
abl
detect
mopvnp
differ
lasv
term
genet
evolut
characterist
thu
far
report
develop
antibodi
antigen
detect
system
use
recombin
nucleoprotein
virus
ebola
hemorrhag
fever
marburg
hemorrhag
fever
crimeancongo
hemorrhag
fever
recent
number
highli
pathogen
emerg
viru
infect
human
appear
nipah
viru
enceph
sarscoronaviru
infect
highli
pathogen
avian
influenza
viru
infect
strategi
shown
might
applic
develop
diagnost
system
sever
viral
infect
whose
etiolog
agent
highli
pathogen
human
altern
method
method
use
infecti
virus
